The PCC assay can be used to predict radiosensitivity in biopsy cultures irradiated with different types of radiation

  • Authors:
    • Masao Suzuki
    • Chizuru Tsuruoka
    • Takashi Nakano
    • Tatsuya Ohno
    • Yoshiya Furusawa
    • Ryuichi Okayasu
  • View Affiliations

  • Published online on: December 1, 2006     https://doi.org/10.3892/or.16.6.1293
  • Pages: 1293-1299
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to identify potential biomarkers for radiosensitivity using the relationship between cell killing and the yield of excess chromatin fragments detected with the premature chromosome condensation (PCC) technique. This method was applied to primary cultured cells obtained from biopsies from patients. Six primary culture biopsies were obtained from 6 patients with carcinoma of the cervix before starting radiotherapy. The cultures were irradiated with two different LET carbon-ion beams (LET = 13 keV/µm, 77.1±2.8 keV/µm) and 200 kV X-rays. The carbon-ion beams were produced by Heavy Ion Medical Accelerator in Chiba (HIMAC). PCC was performed using the polyethylene glycol-mediated cell fusion technique. The yield of excess chromatin fragments were measured by counting the number of unrejoined chromatin fragments detected with the PCC technique after a 24-h post-irradiation incubation period. Obtained results indicated that cultures which were more sensitive to killing were also more susceptible to the induction of excess chromatin fragments. Furthermore there was a good correlation between cell killing and excess chromatin fragments among the 6 cell cultures examined. There is also evidence that the induction of excess chromatin fragments increased with increasing LET as well as cell-killing effect in the same cell culture. The data reported here support the idea that the yield of excess chromatin fragments detected with the PCC technique might be useful for predicting the radiosensitivity of cells contained in tumor tissue, and to predict responses to different radiation types.

Related Articles

Journal Cover

December 2006
Volume 16 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Suzuki M, Tsuruoka C, Nakano T, Ohno T, Furusawa Y and Okayasu R: The PCC assay can be used to predict radiosensitivity in biopsy cultures irradiated with different types of radiation. Oncol Rep 16: 1293-1299, 2006
APA
Suzuki, M., Tsuruoka, C., Nakano, T., Ohno, T., Furusawa, Y., & Okayasu, R. (2006). The PCC assay can be used to predict radiosensitivity in biopsy cultures irradiated with different types of radiation. Oncology Reports, 16, 1293-1299. https://doi.org/10.3892/or.16.6.1293
MLA
Suzuki, M., Tsuruoka, C., Nakano, T., Ohno, T., Furusawa, Y., Okayasu, R."The PCC assay can be used to predict radiosensitivity in biopsy cultures irradiated with different types of radiation". Oncology Reports 16.6 (2006): 1293-1299.
Chicago
Suzuki, M., Tsuruoka, C., Nakano, T., Ohno, T., Furusawa, Y., Okayasu, R."The PCC assay can be used to predict radiosensitivity in biopsy cultures irradiated with different types of radiation". Oncology Reports 16, no. 6 (2006): 1293-1299. https://doi.org/10.3892/or.16.6.1293